← Leaderboards
Ashish Harish Shah
University Of Miami School Of Medicine
$191,962
Attributed
$383,923
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $204.5K · FY2023–24$250K$187.5K$125K$62.5K$0
'23
'24
Funding mix
By agency
NIH$383,923 · 1
By mechanism
R21$383,923 · 1
Top collaborators
- Macarena I De La Fuente2 shared
Most similar at University Of Miami School Of Medicine
Same institution · by research overlap
- Edward W Harhaj$12,325,910
- Ramiro Ernesto Verdun$3,654,446
- Nima Sharifi$12,617,877
- Macarena I De La Fuente$191,962
Others in their field
Other Rising Stars on “Adult”
- Jennifer Lee O'Brien · University Of South Florida$15,110,862
- Daniel Hunter Reirden · Westat, Inc.$15,038,020
- Daofeng Li · Salk Institute For Biological Studies$9,887,266
- Gregory Sorenson · University Of Maryland Baltimore County$9,161,697
- April Carson · University Of Mississippi Med Ctr$9,022,104
- Christine W Hockett · Avera Mckennan$8,908,366
Research focus
AdultAftercareAnaplastic AstrocytomaAnti-Tumor Immune ResponseAttentionBiological ProductsBiomarker DrivenBiomarker IdentificationBiopsyBloodBlood SpecimenBystander EffectCd8-Positive T-LymphocytesCell NucleusChemoradiationChemotherapyClinical CandidateClinical TranslationClinical TrialsComplexCytokineCytosine DeaminaseDigitalAdjuvant Therapy
Grant awards (2)
A Phase 2 biomarker driven, Study of DB107, a Retroviral Replicating Vector, Combined With 5-FC in Patients with Recurrent Glioblastoma or Anaplastic Astrocytoma$204,520
R21 · FY2024 · CA · contact PI
A Phase 2 biomarker driven, Study of DB107, a Retroviral Replicating Vector, Combined With 5-FC in Patients with Recurrent Glioblastoma or Anaplastic Astrocytoma$179,403
R21 · FY2023 · CA · contact PI